1. Kotambail, Ananthapadmanabha, Mathur, Akanksha, Bhat, Shripathy M, Sharma, Podila S, Satyamoorthy, Kapaettu. . GADL1 gene polymorphisms and lithium response in bipolar I disorder: lack of association from an Indian population. In Psychiatric genetics, 25, 39-40. doi:10.1097/YPG.0000000000000066. https://pubmed.ncbi.nlm.nih.gov/25415457/
2. Wu, Tai-Na, Chen, Chih-Ken, Liu, I-Chao, Wu, Lawrence Shih-Hsin, Cheng, Andrew Tai-Ann. 2019. Effects of GADL1 overexpression on cell migration and the associated morphological changes. In Scientific reports, 9, 5298. doi:10.1038/s41598-019-41689-x. https://pubmed.ncbi.nlm.nih.gov/30923325/
3. Winge, Ingeborg, Teigen, Knut, Fossbakk, Agnete, Kämpe, Olle, Haavik, Jan. 2015. Mammalian CSAD and GADL1 have distinct biochemical properties and patterns of brain expression. In Neurochemistry international, 90, 173-84. doi:10.1016/j.neuint.2015.08.013. https://pubmed.ncbi.nlm.nih.gov/26327310/
4. Wu, Tai-Na, Lee, Chau-Shoun, Wu, Bo-Jian, Wu, Lawrence Shih-Hsin, Cheng, Andrew Tai-Ann. 2019. Immunophenotypes associated with bipolar disorder and lithium treatment. In Scientific reports, 9, 17453. doi:10.1038/s41598-019-53745-7. https://pubmed.ncbi.nlm.nih.gov/31767892/
5. Chen, Chien-Hsiun, Lee, Chau-Shoun, Lee, Ming-Ta Michael, Chen, Yuan-Tsong, Cheng, Andrew Tai-Ann. 2013. Variant GADL1 and response to lithium therapy in bipolar I disorder. In The New England journal of medicine, 370, 119-28. doi:10.1056/NEJMoa1212444. https://pubmed.ncbi.nlm.nih.gov/24369049/
智鼠故事 
